BSE filing, BSE: 544463. Summary written from the filing by ALFA Finder's alert engine.
Repono Ltd: key numbers
- Share price
- ₹70.00
- Market cap
- ₹71.95 Cr
- Revenue (annual)
- ₹65.27 Cr
- Net profit (annual)
- ₹6.58 Cr
- P/E (TTM)
- 10.9×Sector 32.3×
- Promoter holding
- 72.47%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Repono Ltd
All →Repono H1 FY27 Results: Net Profit ₹3.5 Cr, Up 9.4% YoY
Repono Ltd reported revenue from operations of ₹36.2 Cr (+18.7% YoY) and net profit of ₹3.5 Cr (+9.4% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.5 Cr · +9.4% YoY
Repono Board Meeting Date
Repono Limited will hold a board meeting on 13 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results.
Repono Other Announcement
Repono Ltd filed its half-yearly shareholding pattern as of September 30, 2026. Promoter and promoter group hold 72.47% of shares, a routine compliance disclosure.
Repono Other Announcement
Repono Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 30, 2026. This is a routine compliance disclosure.
Repono Capacity Expansion
Repono Ltd received Engineering Scale Plan approval from North Central Railways for its upcoming greenfield rail-fed petroleum oil terminal at Mathura, Uttar Pradesh.
Repono Business Update
Repono Ltd's step-down subsidiary received approval from North Central Railway for a Gati Shakti Cargo Terminal. The approval for the Engineering Scale Plan allows development at Ajhai Station.
- From
- North Central Railway, Agra Division
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr